Evolutionary Origin of Human PALB2 Germline Pathogenic Variants
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411343 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jia Sheng Chian und 2 weiteren Autor:innen. Beteiligte Einrichtung: MoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of…. Hauptthemen laut MEDLINE: Breast Neoplasms, Fanconi Anemia Complementation Group N Protein, Germ-Line Mutation, Ovarian Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Macau Science and Technology Development Fund, the University of Macau, the Faculty of Health Sciences, University of Macau.
Abstract (Originalsprache)
PALB2 (Partner and localizer of BRCA2) is crucial for repairing DNA double-stranded breaks (DSBs) through homologous recombination (HR). Germline pathogenic variation in PALB2 disrupts DNA damage repair and increases the risk of Fanconi Anemia, breast cancer, and ovarian cancer. Determination of the evolutionary origin of human PALB2 variants will promote a deeper understanding of the biological basis of PALB2 germline variation and its roles in human diseases. We tested the evolution origin for 1444 human PALB2 germline variants, including 484 pathogenic and 960 benign variants. We performed a phylogenic analysis by tracing the variants in 100 vertebrates. However, we found no evidence to show that cross-species conservation was the origin of PALB2 germline pathogenic variants, but it is indeed a rich source for PALB2 germline benign variants. We performed a paleoanthropological analysis by tracing the variants in over 5000 ancient humans. We identified 50 pathogenic in 71 ancient humans dated from 32,895 to 689 before the present, of which 90.1% were dated within the recent 10,000 years. PALB2 benign variants were also highly shared with ancient humans. Data from our study reveal that human PALB2 pathogenic variants mostly arose in recent human history.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao.
ORCID-Profile: San Ming Wang
Förderung
- the Macau Science and Technology Development Fund
- the University of Macau
- the Faculty of Health Sciences, University of Macau
Zitieren
APA
Chian, J. S., Li, J., & Wang, S. M. (2023). Evolutionary Origin of Human PALB2 Germline Pathogenic Variants. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411343
Vancouver
Chian JS, Li J, Wang SM. Evolutionary Origin of Human PALB2 Germline Pathogenic Variants. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411343
BibTeX
@article{Chian2023,
author = {Chian, Jia Sheng and Li, Jiaheng and Wang, San Ming},
title = {Evolutionary Origin of Human PALB2 Germline Pathogenic Variants},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411343}
}
EUVIMED